Taysha Gene Therapies Inc
Taysha Gene Therapies Inc (TSHA) Covered Calls
As of September 29, 2026, TSHA has 11 covered call opportunities in the coming three months. Return ranges from 10.3 to 115.2% until expiration. Annualized return ranges from 41.6 to 207.1%. The nearest expiration is November 20, 2026. Maximum potential profit is $538.
Read more
Running TSHA covered calls helps you generate consistent income from Taysha Gene Therapies Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Taysha Gene Therapies Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TSHA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TSHA stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TSHA covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Taysha Gene Therapies Inc covered call is worth writing.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments.
The company was incorporated in 2019 and is based in Dallas, Texas.
Income-focused investors, long-term TSHA holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TSHA covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Taysha Gene Therapies Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile70.63% Elevated
- Market cap (M$)1,626
- 52 weeks high-31.64%
- 52 weeks low60.97%
- Analyst recommendationStrong Buy
1.08 - Target price$13.00
175.70% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-0.43
- EPS growth next 5 years10.86%
As of September 29, 2026
| 2027-04-16 | 203 | 10.00 | 114.13 | 0.05 | 1.05 | 538.00 | 115.20 | 207.14 | -1.07 | +0.32 | 2 | 1.00 |
| 2027-04-16 | 203 | 9.00 | 92.72 | 0.25 | 1.20 | 458.00 | 98.07 | 176.34 | -5.35 | +0.39 | 9 | 0.95 |
| 2027-01-15 | 112 | 7.00 | 49.89 | 0.15 | 1.00 | 248.00 | 53.10 | 173.07 | -3.21 | +0.38 | 15 | 0.85 |
| 2027-04-16 | 203 | 8.00 | 71.31 | 0.10 | 1.10 | 343.00 | 73.45 | 132.06 | -2.14 | +0.37 | 0 | 1.00 |
| 2027-04-16 | 203 | 7.00 | 49.89 | 0.20 | 1.20 | 253.00 | 54.18 | 97.41 | -4.28 | +0.42 | 1 | 1.00 |
| 2027-01-15 | 112 | 6.00 | 28.48 | 0.05 | 1.05 | 138.00 | 29.55 | 96.30 | -1.07 | +0.42 | 22 | 1.00 |
| 2026-11-20 | 56 | 5.00 | 7.07 | 0.30 | 0.55 | 63.00 | 13.49 | 87.93 | -6.42 | +0.47 | 20 | 0.25 |
| 2027-04-16 | 203 | 6.00 | 28.48 | 0.40 | 1.40 | 173.00 | 37.04 | 66.61 | -8.57 | +0.51 | 30 | 1.00 |
| 2027-01-15 | 112 | 5.00 | 7.07 | 0.40 | 1.40 | 73.00 | 15.63 | 50.94 | -8.57 | +0.57 | 6 | 1.00 |
| 2026-12-18 | 84 | 5.00 | 7.07 | 0.15 | 0.70 | 48.00 | 10.28 | 44.66 | -3.21 | +0.48 | 245 | 0.55 |
As of September 29, 2026
Sell covered calls with the data behind you
Find the best TSHA covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→